
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Movano Inc (MOVE)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MOVE (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -28.95% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 27.72M USD | Price to earnings Ratio - | 1Y Target Price 30 |
Price to earnings Ratio - | 1Y Target Price 30 | ||
Volume (30-day avg) 21755 | Beta 0.19 | 52 Weeks Range 1.16 - 8.85 | Updated Date 03/30/2025 |
52 Weeks Range 1.16 - 8.85 | Updated Date 03/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.8 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -3198.83% |
Management Effectiveness
Return on Assets (TTM) -88.72% | Return on Equity (TTM) -181.25% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -1883085 | Price to Sales(TTM) 10.3 |
Enterprise Value -1883085 | Price to Sales(TTM) 10.3 | ||
Enterprise Value to Revenue 22.15 | Enterprise Value to EBITDA -1.24 | Shares Outstanding 6596560 | Shares Floating 5086219 |
Shares Outstanding 6596560 | Shares Floating 5086219 | ||
Percent Insiders 17.33 | Percent Institutions 13.84 |
Analyst Ratings
Rating 4 | Target Price 30 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Movano Inc

Company Overview
History and Background
Movano Inc. was founded in 2018. It focuses on developing non-invasive wearable solutions to continuously monitor glucose and other health metrics. They have been actively working towards FDA clearance for their technologies.
Core Business Areas
- Health Monitoring Devices: Development of wearable devices for continuous health monitoring, primarily focused on non-invasive glucose monitoring and other vital signs.
- Data Analytics Platform: Development of a platform to collect, analyze, and present health data to users and healthcare providers.
Leadership and Structure
The leadership team consists of key executives in technology, healthcare, and business. They operate under a traditional corporate structure with departments focusing on R&D, marketing, and operations.
Top Products and Market Share
Key Offerings
- Evie Ring: Movano's lead product is the Evie Ring, a smart ring designed for women. It is designed to measure vital signs and other health metrics. It is currently awaiting FDA approval for certain health tracking features. The smart ring market is competitive, with players like Oura and Circular offering similar products.
Market Dynamics
Industry Overview
The wearable health technology market is experiencing rapid growth driven by increased consumer interest in personal health monitoring and advancements in sensor technology. The market is highly competitive with numerous established players and emerging startups.
Positioning
Movano Inc. is positioned as an innovator in the wearable health technology space, with a focus on non-invasive glucose monitoring and women's health. Their Evie Ring is aimed at disrupting the market by providing stylish and data rich information. The accuracy of their sensors will ultimately determine success.
Total Addressable Market (TAM)
The TAM for wearable health technology is estimated to be in the tens of billions of dollars and expected to grow further. Movano is positioned to capture a portion of this market through innovative devices and features.
Upturn SWOT Analysis
Strengths
- Innovative technology
- Focus on women's health
- Potential for non-invasive glucose monitoring
Weaknesses
- Reliance on successful product development and FDA clearance
- Limited market presence compared to established competitors
- Negative earning per share (EPS)
Opportunities
- Partnerships with healthcare providers
- Expansion into new health monitoring areas
- Growing demand for wearable health technology
Threats
- Competition from established players
- Regulatory hurdles
- Technological obsolescence
Competitors and Market Share
Key Competitors
- FIT
- AAPL
- ONEM
Competitive Landscape
Movano Inc. faces stiff competition from established players with significant market share and resources. The company's success hinges on differentiating itself through innovative technology and a strong brand.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Movano Inc.'s historical growth is characterized by product development and preclinical testing, with minimal revenue to date.
Future Projections: Future growth depends heavily on the successful commercialization of their products, regulatory approvals, and market adoption. Analysts' estimates vary widely due to the high uncertainty.
Recent Initiatives: Recent initiatives include ongoing clinical trials, product development efforts, and preparations for regulatory submissions.
Summary
Movano is a speculative investment due to its early stage and dependence on technological breakthroughs and regulatory approvals. The company's focus on women's health and non-invasive monitoring presents potential, but significant risks remain due to stiff competition and high cash burn. Successful FDA clearance and market acceptance of their products are crucial for long-term viability. The company needs to maintain a solid cash runway and navigate the regulatory landscape to succeed.
Similar Companies

AAPL

Apple Inc



AAPL

Apple Inc
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on individual risk tolerance and due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Movano Inc
Exchange NASDAQ | Headquaters Pleasanton, CA, United States | ||
IPO Launch date 1999-08-05 | CEO, President & Director Dr. John Mastrototaro Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 30 | Website https://movano.com |
Full time employees 30 | Website https://movano.com |
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.